We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Study Details

8398-408 5a or 5b

Back To Current Studies

Healthy Adults, Age 18-60

Study Number

8398-408 5a or 5b

Group

Cohort 5a or 5b

Gender

both

Age

18-60

Location

Dallas, Texas

Compensation

$9,694

Study Dates

Jul. 20 - Sep. 29, 2021

Additional Information

This is an investigational research study for a drug being developed for the treatment of certain types of blood disorders and kidney diseases.  The study drug is an antibody, a type of protein that is involved in the immune system. You will receive a single, 60-minute IV (intravenous) dose of the study drug or placebo (inactive drug) into a vein in your arm. This is the first time this drug will be given to humans.

• Healthy Adults, age 18-60

• BMI (body mass index) 18-32

• Join us for a stay of 8 days and 10 outpatient visits

• Compensation up to $9,694 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment! 

Cohort 5a: Jun 10, 15, 21

Check-In: Jul 20
Check-Out:  Jul 27

Follow up visit:  Jul 28

Follow up visit:  Jul 31

Follow up visit:  Aug 01

Follow up visit:  Aug 04

Follow up visit:  Aug 18

Follow up visit:  Aug 25

Follow up visit:  Sep 01

Follow up visit:  Sep 08

Follow up visit: Sep 15

Follow up visit: Sep 29

 

OR 

 

Cohort 5b: 

Check-In: Aug 02
Check-Out:  Aug 09

Follow up visit: Aug 10

Follow up visit:  Aug 13

Follow up visit:  Aug 14

Follow up visit:  Aug 17

Follow up visit:  Aug 31

Follow up visit:  Sep 07

Follow up visit:  Sep 14

Follow up visit:  Sep 21

Follow up visit: Sep 28

Follow up visit: Oct 12

Study Number

8398-408 5a or 5b

Group

Cohort 5a or 5b

Gender

both

Age

18-60

Location

Dallas, Texas

Compensation

$9,694

Study Dates

Jul. 20 - Sep. 29, 2021

Additional Information

This is an investigational research study for a drug being developed for the treatment of certain types of blood disorders and kidney diseases.  The study drug is an antibody, a type of protein that is involved in the immune system. You will receive a single, 60-minute IV (intravenous) dose of the study drug or placebo (inactive drug) into a vein in your arm. This is the first time this drug will be given to humans.

• Healthy Adults, age 18-60

• BMI (body mass index) 18-32

• Join us for a stay of 8 days and 10 outpatient visits

• Compensation up to $9,694 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment! 

Cohort 5a: Jun 10, 15, 21

Check-In: Jul 20
Check-Out:  Jul 27

Follow up visit:  Jul 28

Follow up visit:  Jul 31

Follow up visit:  Aug 01

Follow up visit:  Aug 04

Follow up visit:  Aug 18

Follow up visit:  Aug 25

Follow up visit:  Sep 01

Follow up visit:  Sep 08

Follow up visit: Sep 15

Follow up visit: Sep 29

 

OR 

 

Cohort 5b: 

Check-In: Aug 02
Check-Out:  Aug 09

Follow up visit: Aug 10

Follow up visit:  Aug 13

Follow up visit:  Aug 14

Follow up visit:  Aug 17

Follow up visit:  Aug 31

Follow up visit:  Sep 07

Follow up visit:  Sep 14

Follow up visit:  Sep 21

Follow up visit: Sep 28

Follow up visit: Oct 12

Calculate Your BMI!

Calculate Your BMI!